NLS PHARMACEUTICS LTD

CUSIP: H57830111 Class: *W EXP 02/02/202

Hudson Bay Capital Management LP's Holding History (CIK: 0001393825)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 71,356 Value ($000) $1 Avg Close Range
Q3 2024
Shares 71,356 Value ($000) $1 Avg Close Range
Q2 2024
Shares 100,000 Value ($000) $3 Avg Close Range
Q1 2024
Shares 100,000 Value ($000) $5 Avg Close Range
Q4 2023
Shares 100,000 Value ($000) $6 Avg Close Range
Q3 2023
Shares 100,000 Value ($000) $11 Avg Close Range
Q2 2023
Shares 100,000 Value ($000) $10 Avg Close Range
Q1 2023
Shares 100,000 Value ($000) $15 Avg Close Range
Q4 2022
Shares 100,000 Value ($000) $28 Avg Close Range
Q3 2022
Shares 100,000 Value ($000) $25 Avg Close Range
Q2 2022
Shares 100,000 Value ($000) $12 Avg Close Range
Q1 2022
Shares 100,000 Value ($000) $38 Avg Close Range
Q4 2021
Shares 200,000 Value ($000) $165 Avg Close Range
Q3 2021
Shares 200,000 Value ($000) $154 Avg Close Range
Q2 2021
Shares 200,000 Value ($000) $192 Avg Close Range
Q1 2021
Shares 200,000 Value ($000) $190 Avg Close Range